Allogeneic stem cell transplantation for non-de novo AML or advanced myelodysplastic syndromes: influence of GvHD and donor lymphocyte infusions on long-term outcome

Bone Marrow Transplant. 2018 Jan;53(1):101-103. doi: 10.1038/bmt.2017.215. Epub 2017 Oct 9.

Authors

P G Hemmati¹, K Pfeifer¹, L G Vuong¹, C F Jehn¹, T H Terwey¹, P le Coutre¹, B Dörken¹, R Arnold¹

Affiliation

¹ Department of Hematology, Oncology and Tumor Immunology, Charité-Universitätsmedizin Berlin, Berlin, Germany.

PMID: 28991253
DOI: 10.1038/bmt.2017.215

No abstract available

Publication types

Letter

MeSH terms

Adolescent
Adult
Aged
Female
Graft vs Host Disease / pathology
Graft vs Host Disease / therapy*
Hematopoietic Stem Cell Transplantation / methods*
Humans
Leukemia, Myeloid, Acute / pathology
Leukemia, Myeloid, Acute / therapy*
Lymphocytes / metabolism*
Male
Middle Aged
Retrospective Studies
Transplantation Conditioning / methods*
Transplantation, Homologous / methods*
Treatment Outcome
Young Adult